Population
Patients with connective tissue disease associated pulmonary arterial hypertension (CTD-PAH)
Design
Review
Authors
Loading...
Alerts clinicians to screen systemic sclerosis patients for PAH; extends 2009 guidelines but leaves optimal regimens open for prospective study.
This review highlights the 2009 ESC/ERS guidelines for managing pulmonary hypertension, emphasizing the specific diagnostic and therapeutic considerations for patients with connective tissue disease-associated PAH.
Norifumi Nakanishi (2011) conducted a review in Pulmonary hypertension and connective tissue disease. Connective tissue disease-associated pulmonary arterial hypertension has an estimated prevalence of 7-12% in systemic sclerosis and requires specific targeted treatments such as vasodilators.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: